Mei Pharma earnings were -$38.2M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest MEIP earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$2.7M, down 66.6% from last quarter. For the last reported fiscal year 2024 ending Jun 30, 2024, MEIP reported annual earnings of $17.8M, with -155.8% growth. The next MEIP earnings date is May 7, 2025.
On MEIP's earnings call on Invalid Date, Mei Pharma (NASDAQ: MEIP) reported Q4 2024 earnings per share (EPS) of -$0.40, up 75.9% year over year. Total MEIP earnings for the quarter were -$2.68 million. In the same quarter last year, Mei Pharma's earnings per share (EPS) was -$1.66.
The next MEIP earnings date is Invalid Date. Add MEIP to your watchlist to be reminded of Mei Pharma's next earnings date.
What was MEIP's earnings growth in the past year?
As of Mei Pharma's earnings date in Invalid Date, Mei Pharma's earnings has grown year over year. MEIP earnings in the past year totalled -$38.22 million.
Is Mei Pharma profitable or losing money?
As of the last Mei Pharma earnings report, Mei Pharma is currently losing money. Mei Pharma's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$38.22 million, a 292.59% decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.